Innate immune response after adenoviral gene delivery into skin is mediated by AIM2, NALP3, DAI and mda5

SpringerPlus

Volumn 2, Issue 1, 2013, Pages 1-16

  Schulte, Matthias ^a   Sorkin, Michael ^a   Al Benna, Sammy ^a   Stupka, Jadwiga ^a   Hirsch, Tobias ^a   Daigeler, Adrien ^a   Kesting, Marco Rainer ^a   Steinau, Hans Ulrich ^b   Jacobsen, Frank ^a   Steinstraesser, Lars ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Adenovirus; Gene therapy; Innate immunity; Keratinocytes; Signal transduction; Skin

Indexed keywords

EID: 84878781543     PISSN: None     EISSN: 21931801     Source Type: Journal    
DOI: 10.1186/2193-1801-2-234     Document Type: Article

References (46)

1. Acheson NH (2011) Fundamentals of molecular virology. John Wiley & Sons
2. Akira S, Hoshino K (2003) Myeloid differentiation factor 88-dependent and -independent pathways in toll-like receptor signaling. J Infect Dis 187(Suppl 2):S356-S363.
3. Alexopoulou L, Holt AC, Medzhitov R et al (2001) Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413:732-738.
4. Bauernfeind F, Ablasser A, Kim S et al (2010) An unexpected role for RNA in the recognition of DNA by the innate immune system. RNA Biol 7:151-157.
5. Boukamp PPR, Breitkreutz D, Hornung J, Markham A, Fusenig NE (1988) Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 106:761-771.
6. Bouwstra JA, Honeywell-Nguyen PL, Gooris GS et al (2003) Structure of the skin barrier and its modulation by vesicular formulations. Prog Lipid Res 42:1-36.
7. Brunetti-Pierri N, Palmer DJ, Beaudet AL et al (2004) Acute toxicity after highdose systemic injection of helper-dependent adenoviral vectors into nonhuman primates. Hum Gene Ther 15:35-46.
8. Christensen R, Jensen UB, Jensen TG (2001) Cutaneous gene therapy-an update. Histochem Cell Biol 115:73-82.
9. Delaloye J, Roger T, Steiner-Tardivel QG et al (2009) Innate immune sensing of modified vaccinia virus Ankara (MVA) is mediated by TLR2-TLR6, MDA-5 and the NALP3 inflammasome. PLoS Pathog 5:e1000480.
10. Diebold SS, Kaisho T, Hemmi H et al (2004) Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303:1529-1531.
11. Douglas JT (2007) Adenoviral vectors for gene therapy. Mol Biotechnol 36:71-80.
12. Goubau D, Rehwinkel J, Reis e Sousa C (2010) PYHIN proteins: center stage in DNA sensing. Nat Immunol 11:984-986.
13. Hemmi H, Takeuchi O, Kawai T et al (2000) A Toll-like receptor recognizes bacterial DNA. Nature 408:740-745.
14. Isaacs A, Cox RA, Rotem Z (1963) Foreign nucleic acids as the stimulus to make interferon. Lancet 2:113-116.
15. Ishii KJ, Suzuki K, Coban C et al (2001) Genomic DNA released by dying cells induces the maturation of APCs. J Immunol 167:2602-2607.
16. Janeway CA Jr, Medzhitov R (2002) Innate immune recognition. Annu Rev Immunol 20:197-216.
17. JGT (2012) Gene therapy - clinical trials worldwide. http://www.abedia.com/wiley/. Accessed 19th October 2012.
18. Kanehisa M (2012) KEGG: Kyoto encyclopedia of genes and genomes. Kanehisa laboratories. www.genome.jp/kegg/. Accessed 19th October 2012.
19. Kawai T, Akira S (2006) Innate immune recognition of viral infection. Nat Immunol 7:131-137.
20. Kawai T, Akira S (2008) Toll-like receptor and RIG-I-like receptor signaling. Ann N Y Acad Sci 1143:1-20.
21. Kim SH, Evans CH, Kim S et al (2000) Gene therapy for established murine collagen-induced arthritis by local and systemic adenovirus-mediated delivery of interleukin-4. Arthritis Res 2:293-302.
22. Köllisch GKB, Voelcker V, Wallich R, Behrendt H, Ring J, Bauer S, Jakob T, Mempel M, Ollert M (2005) Various members of the Toll-like receptor family contribute to the innate immune response of human epidermal keratinocytes. Immunology 114:531-541.
23. Lopez CB, Yount JS, Moran TM (2006) Toll-like receptor-independent triggering of dendritic cell maturation by viruses. J Virol 80:3128-3134.
24. Martin DA, Elkon KB (2006) Intracellular mammalian DNA stimulates myeloid dendritic cells to produce type I interferons predominantly through a toll-like receptor 9-independent pathway. Arthritis Rheum 54:951-962.
25. Mulligan RC (1993) The basic science of gene therapy. Science 260:926-932.
26. Muruve DA (2004) The innate immune response to adenovirus vectors. Hum Gene Ther 15:1157-1166.
27. Muruve DA, Petrilli V, Zaiss AK et al (2008) The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response. Nature 452:103-107.
28. Nociari M, Ocheretina O, Schoggins JW et al (2007) Sensing infection by adenovirus: Toll-like receptor-independent viral DNA recognition signals activation of the interferon regulatory factor 3 master regulator. J Virol 81:4145-4157.
29. Raper SE, Chirmule N, Lee FS et al (2003) Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer. Mol Genet Metab 80:148-158.
30. Roberts TL, Idris A, Dunn JA et al (2009) HIN-200 proteins regulate caspase activation in response to foreign cytoplasmic DNA. Science 323:1057-1060.
31. Rux JJ, Burnett RM (2004) Adenovirus structure. Hum Gene Ther 15:1167-1176.
32. Schnell MA, Zhang Y, Tazelaar J et al (2001) Activation of innate immunity in nonhuman primates following intraportal administration of adenoviral vectors. Mol Ther 3:708-722.
33. Steinstraesser L, Rittig A, Gevers K et al (2009) A human full-skin culture system for interventional studies. Eplasty 9:e5.
34. Steinstraesser L, Sorkin M, Niederbichler AD et al (2010) A novel human skin chamber model to study wound infection ex vivo. Arch Dermatol Res 302:357-365.
35. Steinstraesser L, Sorkin M, Jacobsen F et al (2011) Evaluation of signal transduction pathways after transient cutaneous adenoviral gene delivery. BMC Immunol 12:8.
36. Suzuki K, Mori A, Ishii KJ et al (1999) Activation of target-tissue immunerecognition molecules by double-stranded polynucleotides. Proc Natl Acad Sci U S A 96:2285-2290.
37. Takaoka A, Wang Z, Choi MK et al (2007) DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 448:501-505.
38. Tatsis N, Ertl HC (2004) Adenoviruses as vaccine vectors. Mol Ther 10:616-629.
39. Tomic-Canic M, Komine M, Freedberg IM et al (1998) Epidermal signal transduction and transcription factor activation in activated keratinocytes. J Dermatol Sci 17:167-181.
40. Unterholzner L, Keating SE, Baran M et al (2010) IFI16 is an innate immune sensor for intracellular DNA. Nat Immunol 11:997-1004.
41. Worgall S, Wolff G, Falck-Pedersen E et al (1997) Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration. Hum Gene Ther 8:37-44.
42. Yasuda K, Yu P, Kirschning CJ et al (2005) Endosomal translocation of vertebrate DNA activates dendritic cells via TLR9-dependent and -independent pathways. J Immunol 174:6129-6136.
43. Yoneyama M, Fujita T (2007) RIG-I family RNA helicases: cytoplasmic sensor for antiviral innate immunity. Cytokine Growth Factor Rev 18:545-551.
44. Zhang WW (1999) Development and application of adenoviral vectors for gene therapy of cancer. Cancer Gene Ther 6:113-138.
45. Zhang Y, Chirmule N, Gao GP et al (2001) Acute cytokine response to systemic adenoviral vectors in mice is mediated by dendritic cells and macrophages. Mol Ther 3:697-707.
46. Zhu J, Huang X, Yang Y (2007) Innate immune response to adenoviral vectors is mediated by both Toll-like receptor-dependent and -independent pathways. J Virol 81:3170-3180